Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 1/20 | 0.57 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.57 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL755636 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL9751433 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL44028 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL2901529 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL5364867 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL1070643 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL24398977 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL11576564 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL21924992 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL20774497 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203802-A1 | POWDER COMPOSITION, A DISPERSION OF POWDER IN OIL, AND A COSMETIC COMPRISING THE SAME | KAMEI MASANAO | 2009-08-13 | — | — | US | disclosed |
| EP-1416016-B1 | Powder composition, a dispersion of powder in oil, and a cosmetic preparation comprising polyglycerine modified silicone | SHINETSU CHEMICAL CO (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-20060165629-A1 | Powder composition, a dispersion of powder in oil, and a cosmetic comprising the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2006-07-27 | — | — | US | disclosed |
| US-20040091439-A1 | Powder composition, a dispersion of powder in oil, and a cosmetic comprising the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1416016-A1 | Powder composition, a dispersion of powder in oil, and a cosmetic preparation comprising polyglycerine modified silicone | Shin-Etsu Chemical Co., Ltd. (JP) | 2004-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060165629-A1 | Powder composition, a dispersion of powder in oil, and a cosmetic comprising the same | SPECC1L, FANCD2, ALG1 | LPAR1 756/4885LPAR2 1141/4885LPAR3 643/4885 |
| US-20040091439-A1 | Powder composition, a dispersion of powder in oil, and a cosmetic comprising the same | SPECC1L, SIK2, PLIN3 | LPAR1 1735/4885LPAR2 2296/4885LPAR3 1595/4885 |
| US-20090203802-A1 | POWDER COMPOSITION, A DISPERSION OF POWDER IN OIL, AND A COSMETIC COMPRISING THE SAME | FANCD2, SPECC1L, ALG1 | LPAR1 710/4885LPAR2 1003/4885LPAR3 612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.